Treatment of Renal Angiomyolipomas in Tuberous Sclerosis by Beta-blockers | MicrobiomeTrials← Back to trialsNCT02104011
Treatment of Renal Angiomyolipomas in Tuberous Sclerosis by Beta-blockers
CompletedPHASE2INTERVENTIONAL
Trial Details
Start: 2015-05-22Est. Completion: 2017-11-22
Enrollment target: 2 participants Locations- Nephrology department, Bordeaux, France
Other microbiome trials you might be interested in
Renal Angiomyolipoma
The purpose of this prospective study is to assess the safety and efficacy of everolimus in Taiwanese patients with rena…
Taichung, TaiwanEst. completion Oct 10, 2026
Renal Cell Carcinoma (RCC)
Multi-center, single arm, prospective trial to estimate safety, feasibility, technical outcomes, and clinical outcomes o…
Birmingham, United StatesCompleted Nov 19, 2025